Skip to main content
. 2021 Feb 17;21:114. doi: 10.1186/s12935-021-01747-9

Fig. 1.

Fig. 1

a Expression of SNHG3 in 348 esophageal cancer patients. b Expression of miR-186-5p in 348 esophageal cancer patients. c Expression of SNHG3 in recurrence and non-recurrence groups. d Expression of miR-186-5p in recurrence and non-recurrence groups. e Expression of METTL3, METTL14, FTO and ALKBH5 in 348 esophageal cancer patients. f Expression of METTL3, METTL14, FTO and ALKBH5 in recurrence and non-recurrence groups. g Expression of SNHG3 in esophageal cancer cells. h Expression of miR-186-5p in esophageal cancer cells